Cases & Deals

Sepracor goes head to head against Wyeth in three patent interferences

Clients Sepracor, Inc.

Jones Day represented Sepracor, Inc. in three patent interferences against Wyeth involving O-desmethylvenlafaxine succinate, and pharmaceutical compositions and dosage forms containing such salt.

Jerussi (Sepracor) v. Hadfield (Wyeth), Interference No. 105,671;
Hadfield (Wyeth) v. Jerussi (Sepracor), Interference No. 105,685;
Hadfield (Wyeth) v. Jerussi (Sepracor), Interference No. 105,689

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.